Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas

MLA

Amy Hillen, et al. “Trehalose as Quantitative Biomarker for in Vivo Diagnosis and Treatment Follow-up in Cryptococcomas.” Translational Research, vol. 230, Apr. 2021, pp. 111–22. EBSCOhost, https://doi.org/10.1016/j.trsl.2020.11.001.

APA

Amy Hillen, Tania C. Sorrell, Jennifer Poelmans, Uwe Himmelreich, Katrien Lagrou, Akila Weerasekera, Liesbeth Vanherp, Anca R Croitor-Sava, & Greetje Vande Velde. (2021). Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas. Translational Research, 230, 111–122. https://doi.org/10.1016/j.trsl.2020.11.001

Chicago

Amy Hillen, Tania C. Sorrell, Jennifer Poelmans, Uwe Himmelreich, Katrien Lagrou, Akila Weerasekera, Liesbeth Vanherp, Anca R Croitor-Sava, and Greetje Vande Velde. 2021. “Trehalose as Quantitative Biomarker for in Vivo Diagnosis and Treatment Follow-up in Cryptococcomas.” Translational Research 230 (April): 111–22. doi:10.1016/j.trsl.2020.11.001.